Cheng Liu
Chief Executive Officer at ESTRELLA IMMUNOPHARMA, INC.
Net worth: 368 822 $ as of 2024-03-30
Profile
Cheng Liu is the founder of Eureka Therapeutics, Inc. (founded in 2006) and holds the title of President, Chief Executive Officer & Director.
Dr. Liu is also the founder of InvisiShield Technologies Ltd., Estrella Biopharma, Inc...
Dr. Liu's current job is Chairman, President & Chief Executive Officer at Estrella Immunopharma, Inc. Dr. Liu is also a Non-Executive Director at JW (Cayman) Therapeutics Co. Ltd.
since 2020.
Dr. Liu's former job was as a Principal Scientist at Chiron Corp.
Dr. Liu was also a Member-Adversary & Executive Committee at SAPA-West from 1998 to 2007.
Dr. Liu's education includes an undergraduate and graduate degree from Peking University and a doctorate degree from the University of California, Berkeley.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2023-09-28 | 297,437 ( 0.81% ) | 368 822 $ | 2024-03-30 |
Cheng Liu active positions
| Companies | Position | Start |
|---|---|---|
| JW (CAYMAN) THERAPEUTICS CO. LTD | Director/Board Member | 2020-06-29 |
| ESTRELLA IMMUNOPHARMA, INC. | Chief Executive Officer | - |
Eureka Therapeutics, Inc.
 Eureka Therapeutics, Inc. BiotechnologyHealth Technology Eureka Therapeutics, Inc. develops therapeutic monoclonal antibodies for cancer indication and treatment. It focuses on the discovery of fully-human antibody drugs for the treatment of cancer and utilizing its antibody drug discovery and engineering technologies, and advancing therapies for targeting previously inaccessible cancer antigens. The company was founded by Cheng Liu in 2006 and is headquartered in Emeryville, CA. | Founder | 2010-01-20 |
InvisiShield Technologies Ltd.
 InvisiShield Technologies Ltd. Miscellaneous Commercial ServicesCommercial Services InvisiShield Technologies Ltd. is a Caymanian biotechnology company. The company is based in George Town, Cayman Islands. The company was founded by Cheng Liu, Warner C. Greene. Cheng Liu has been the CEO since incorporation. | Chief Executive Officer | - |
Estrella Biopharma, Inc.
 Estrella Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Estrella Biopharma, Inc. is a preclinical stage biopharmaceutical company that develops cell therapies for patients with blood cancers and solid tumors. The private company is based in Emeryville, CA. The CEO of the company is Cheng Liu. | Founder | - |
Former positions of Cheng Liu
| Companies | Position | End |
|---|---|---|
| SAPA-West | Corporate Officer/Principal | 2006-12-31 |
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Corporate Officer/Principal | - |
Training of Cheng Liu
| Peking University | Graduate Degree |
| University of California, Berkeley | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| JW (CAYMAN) THERAPEUTICS CO. LTD | Health Technology |
| Private companies | 6 |
|---|---|
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Health Technology |
Eureka Therapeutics, Inc.
Eureka Therapeutics, Inc. BiotechnologyHealth Technology Eureka Therapeutics, Inc. develops therapeutic monoclonal antibodies for cancer indication and treatment. It focuses on the discovery of fully-human antibody drugs for the treatment of cancer and utilizing its antibody drug discovery and engineering technologies, and advancing therapies for targeting previously inaccessible cancer antigens. The company was founded by Cheng Liu in 2006 and is headquartered in Emeryville, CA. | Health Technology |
| SAPA-West | |
InvisiShield Technologies Ltd.
InvisiShield Technologies Ltd. Miscellaneous Commercial ServicesCommercial Services InvisiShield Technologies Ltd. is a Caymanian biotechnology company. The company is based in George Town, Cayman Islands. The company was founded by Cheng Liu, Warner C. Greene. Cheng Liu has been the CEO since incorporation. | Commercial Services |
Estrella Biopharma, Inc.
Estrella Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Estrella Biopharma, Inc. is a preclinical stage biopharmaceutical company that develops cell therapies for patients with blood cancers and solid tumors. The private company is based in Emeryville, CA. The CEO of the company is Cheng Liu. | Health Technology |
| Estrella Immunopharma, Inc. |
- Stock Market
- Insiders
- Cheng Liu
